LECAP Asset Management’s Eli Lilly LLY Stock Holding History

LECAP Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$937K	Sell	1,019 -243	-19%	-$246K	0.35%	122
2025 Q4	$1.36M	Sell	1,262 -455	-26%	-$435K	0.54%	65
2025 Q3	$1.31M	Buy	+1,717	New	+$1.28M	0.46%	86
2025 Q2	–	Sell	-637	Closed	-$526K	–	353
2025 Q1	$526K	Sell	637 -1,708	-73%	-$1.42M	0.12%	229
2024 Q4	$1.81M	Sell	2,345 -263	-10%	-$218K	0.49%	75
2024 Q3	$2.31M	Buy	2,608 +1,848	+243%	+$1.66M	0.5%	68
2024 Q2	$688K	Buy	+760	New	+$608K	0.15%	227
2024 Q1	–	Sell	-689	Closed	-$402K	–	346
2023 Q4	$402K	Buy	+689	New	+$402K	0.15%	230

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LECAP Asset Management's LLY Position: Q1 2026 in Review

LECAP Asset Management reduced its Eli Lilly (LLY) stake by 19% in Q1 2026, selling an estimated $246K and leaving 1,019 shares worth $937K. The position accounts for 0.35% of the portfolio, ranked #122.

LECAP Asset Management first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.31M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

LECAP Asset Management held 1,019 shares of Eli Lilly worth $937K as of Q1 2026.
LECAP Asset Management sold 243 Eli Lilly shares in Q1 2026, an estimated $246K.
Eli Lilly made up 0.35% of LECAP Asset Management's portfolio in Q1 2026, its #122 holding.
LECAP Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
LECAP Asset Management's Eli Lilly position peaked at $2.31M in Q3 2024.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.